Genetech's Herceptin Increases Risk of Heart Defects (tags)
The breast cancer drug called Herceptin manufactured by Genentech has shown to increase the risks of heart defects and cardiotoxicity in older patients. This supports evidence provided by the ALF that states animal tests are not only cruel, though are also ineffective at determining the risk to humans.